FDA Approves Once-weekly Trulicity to Treat Type 2 Diabetes - Diabetes Health

FDA Approves Once-weekly Trulicity to Treat Type 2 Diabetes - Diabetes Health:



"Brenda Neugent | Oct 11, 2014

The U.S. Food and Drug Administration recently approved Trulicity, a once-weekly injectable to treat adults with type 2 diabetes.

Also known as dulaglutide, Trulicity is a glucagon-like peptide-1 (GLP-1) receptor agonist, which helps normalize blood sugar levels by encouraging the release of insulin, which helps the body better use available blood glucose, while suppressing the stimulation of glucose production."



'via Blog this'